These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2873222)

  • 1. Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activity.
    Gristwood RW; Eden RJ; Owen DA; Taylor EM
    J Pharm Pharmacol; 1986 Jun; 38(6):452-9. PubMed ID: 2873222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action.
    Gristwood RW; Comer MB; Eden RJ; Taylor EM; Turner JA; Wallduck M; Owen DA
    Br J Pharmacol; 1988 Apr; 93(4):893-901. PubMed ID: 3390657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
    Collis MG; Keddie JR; Rouse W
    Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
    Wynne DG; Poole-Wilson PA; Harding SE
    Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of responses to a selective phosphodiesterase III inhibitor, SK&F 94120, on isolated myocardium, including human ventricular myocardium from "end-stage" failure patients.
    Gristwood RW; English TA; Wallwork J; Sampford KA; Owen DA
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):719-27. PubMed ID: 2442540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).
    Taylor EM; Cameron D; Eden RJ; Fielden R; Owen DA
    J Cardiovasc Pharmacol; 1981; 3(2):337-54. PubMed ID: 6166805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
    von Meel JC
    Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the cardiac actions of flosequinan in vitro.
    Gristwood RW; Beleta J; Bou J; Cardelús I; Fernández AG; Llenas J; Berga P
    Br J Pharmacol; 1992 Apr; 105(4):985-91. PubMed ID: 1324061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive and vasodilator actions of SK&F 24260, a new dihydropyridine derivative.
    Fielden R; Owen DA; Taylor EM
    Br J Pharmacol; 1974 Nov; 52(3):323-32. PubMed ID: 4458842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cardiovascular effect of Cordemcura on various animal models in vivo].
    Rohde E; Muschick P; Modersohn D; Landmann H; Löwe H
    Pharmazie; 1986 Mar; 41(3):194-5. PubMed ID: 3714794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SK & F 95018, a vasodilator/beta-adrenoceptor antagonist.
    Swayne GT; Owen DA; Taylor EM; Eden RJ; Slater RA; Howson W
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):251-66. PubMed ID: 2892473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the autonomic nervous system with SK&F 92657, a new antihypertensive agent causing direct arterial vasodilatation and beta-adrenoceptor blockade.
    Taylor EM; Eden RJ; Fielden R; Owen DA
    J Cardiovasc Pharmacol; 1981; 3(2):355-68. PubMed ID: 6166806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function.
    Murray KJ; Eden RJ; Dolan JS; Grimsditch DC; Stutchbury CA; Patel B; Knowles A; Worby A; Lynham JA; Coates WJ
    Br J Pharmacol; 1992 Oct; 107(2):463-70. PubMed ID: 1422592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of LAS 31180, a new inotropic/vasodilator quinolone derivative.
    Gras J; Cardelús I; Beleta J; Gristwood RW; Palacios JM; Llenas J
    Arzneimittelforschung; 2000 Nov; 50(11):980-6. PubMed ID: 11148864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
    Brown L; Erdmann E
    Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPC-18790, a novel positive inotropic agent, has both arterial and venous vascular dilating actions in the dog.
    Fujiki H; Mori T; Yoshida K; Imaizumi T; Tominaga M
    Eur J Pharmacol; 1996 Oct; 313(3):191-200. PubMed ID: 8911915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.